A phase I/II randomized study of Debio1143 combined with concurrent chemoradiation therapy (CCRT) in patients with locally advanced squamous cell carcinoma of the head and neck (LA-SCCHN)

C Le Tourneau (1), Y Tao (2), J-P Delord (3), S Brienza (4), G Vuagniaux (4), M-P Sablin (1), C Zanna (4), J Bourhis (5)

Presented at ASCO 2014, Chicago, USA

(1) Institut Curie, Paris, France

(2) Institut Gustave Roussy, Villejuif, France

(3) Centre Claudius Regaud, Toulouse, France

(4) Debiopharm International SA, Lausanne, Switzerland

(5) Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland